Structural studies of human alkaline phosphatase in complex with strontium: Implication for its secondary effect in bones

Protein Science

Volumn 15, Issue 7, 2006, Pages 1691-1700

  Llinas, Paola ^a   Masella, Michel ^a   Stigbrand, Torgny ^b   Ménez, André ^a   Stura, Enrico A ^a   Le Du, Marie Hélène ^a  

^a DIF   (France)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Alkaline phosphatase; Crystal structure; Hypophosphatasia; Strontium

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE PLACENTA ISOENZYME; CALCIUM ION; STRONTIUM;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; METAL BINDING; PRIORITY JOURNAL;

EID: 33745698741     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.062123806     Document Type: Article

References (65)

1. Boivin, G. and Meunier, P.J. 2003. The mineralization of bone tissue: A forgotten dimension in osteoporosis research. Osteoporos. Int. 14: 19-24.
2. Cabrera, W.E., Schrooten, I., De Broe, M.E., and D'Haese, P.C. 1999. Strontium and bone. J. Bone Miner. Res. 14: 661-668.
3. Chen, L., Neidhart, D., Kohlbrenner, W.M., Mandecki, W., Bell, S., Sowadski, J., and Abad-Zapatero, C. 1992. 3-D structure of a mutant (Asp101 → Ser) of E. coli alkaline phosphatase with higher catalytic activity. Protein Eng. 5: 605-610.
4. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50: 760-763.
5. 2+dications and with a target enzyme peptide. J. Chem. Phys. 119: 1874-1878.
6. Dealwis, C.G., Brennan, C., Christianson, K., Mandecki, W., and Abad-Zapatero, C. 1995a. Crystallographic analysis of reversible metal binding observed in a mutant (Asp153 → Gly) of Escherichia coli alkaline phosphatase. Biochemistry 34: 13967-13973.
7. Dealwis, C.G., Chen, L., Brennan, C., Mandecki, W., and Abad-Zapatero, C. 1995b. 3-D structure of the D153G mutant of Escherichia coli alkaline phosphatase: An enzyme with weaker magnesium binding and increased catalytic activity. Protein Eng. 8: 865-871.
8. De Backer, M., McSweeney, S., Rasmussen, H.B., Riise, B.W., Lindley, P., and Hough, E. 2002. The 1.9 Å crystal structure of heat-labile shrimp alkaline phosphatase. J. Mol. Biol. 318: 1265-1274.
9. De Backer, M.M.E., McSweeney, S., Lindley, P.F., and Hough, E. 2004. Ligand-binding and metal-exchange crystallographic studies on shrimp alkaline phosphatase. Acta Crystallogr. D Biol. Crystallogr. 60: 1555-1561.
10. D'Haese, P.C., Schrooten, I., Goodman, W.G., Cabrera, W.E., Lamberts, L.V., Elseviers, M.M., Couttenye, M.-M., and De Broe, M.E. 2000. Increased bone strontium levels in hemodialysis patients with osteomalacia. Kidney Int. 57:1107-1114.
11. Di Mauro, S., Manes, T., Hessle, H., Kozlenkov, A., Pizauro, J.M., Hoylaerts, M.F., and Millán, J.L. 2002. Kinetic characterization of hypophosphatasia mutations with physiological substrates. J. Bone Miner. Res. 17: 1383-1391.
12. Doellgast, G.J. and Fishman, W.H. 1977. Inhibition of human placental-type alkaline phosphatase variants by peptides containing L-leucine. Clin. Chim. Acta 75: 449-454.
13. Fishman, W.H. and Sie, H.G. 1971. Organ-specific inhibition of human alkaline phosphatase isoenzymes of liver, bone, intestine and placenta; L-phenylalanine, L-tryptophan and L-homoarginine. Enzymologia 41: 140-167.
14. Francis, R.M. and Selby, P.L. 1997. Osteomalacia. Baillieres Clin. Endocrinol. Metab. 11: 145-163.
15. 31P nuclear magnetic resonance of phosphoenzyme intermediates of alkaline phosphatase. J. Biol. Chem. 258: 408-416.
16. 113Cd NMR. J. Biol. Chem. 259: 4991-4997.
17. 85Sr therapy. J. Nucl. Med. 40: 585-590.
18. Harmey, D., Hessle, L., Narisawa, S., Johnson, K., Terkeltaub, R., and Millán, J.L. 2004. Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1 and Ank. An integrated model of the pathogenesis of mineralization disorders. Am. J. Pathol. 164: 1199-1209.
19. Harris, H. 1990. The human alkaline phosphatases: What we know and what we don't know. Clin. Chim. Acta 186: 133-150.
20. Henthorn, P.S., Raducha, M., Fedde, K., Lafferty, M.A., and Whyte, M.P. 1992. Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc. Natl. Acad. Sci. 89: 9924-9928.
21. Hessle, L., Johnson, K.A., Anderson, H.C., Narisawa, S., Sali, A., Goding, J.W., Terkeltaub, R., and Millan, J.L. 2002. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl. Acad. Sci. 99: 9445-9449.
22. Holtz, K.M. and Kantrowitz, E.R. 1999. The mechanism of the alkaline phosphatase reaction: Insights from NMR, crystallography and site-specific mutagenesis. FEBS Lett. 462: 7-11.
23. Hoylaerts, M.F., Manes, T., and Millán, J.L. 1997. Mammalian alkaline phosphatases are allosteric enzymes. J. Biol. Chem. 272: 22781-22787.
24. 31P nuclear magnetic resonance study of alkaline phosphatase: The role of inorganic phosphate in limiting the enzyme turnover rate at alkaline pH. Biochemistry 15: 1547-1561.
25. Janeway, C.M., Xu, X., Murphy, J.E., Chaidaroglou, A., and Kantrowitz, E.R. 1993. Magnesium in the active site of Escherichia coli alkaline phosphatase is important for both structural stabilization and catalysis. Biochemistry 32: 1601-1609.
26. Kim, E.E. and Wyckoff, H.W. 1991. Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. J. Mol. Biol. 218: 449-464.
27. Kozlenkov, A., Manes, T., Hoylaerts, M.F., and Millán, J.L. 2002. Function assignment to conserved residues in mammalian alkaline phosphatases. J. Biol. Chem. 277: 22992-22999.
28. Kshirsagar, A.G. 1975. The effect of stable strontium on the alkaline phosphatase activity of rat tissues - In vitro studies. Biochem. Pharmacol. 24: 13-20.
29. Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26: 283-291.
30. Le Du, M.H., Stigbrand, T., Taussig, M.J., Ménez, A., and Stura, E.A. 2001. Crystal structure of alkaline phosphatase from human placenta at 1.8 Å resolution. J. Biol. Chem. 276: 9158-9165.
31. Le Du, M.H., Lamoure, C., Muller, B.H., Bulgakov, O.V., Lajeunesse, E., Menez, A., and Boulain, J.C. 2002. Artificial evolution of an enzyme active site: Structural studies of three highly active mutants of Escherichia coli alkaline phosphatase. J. Mol. Biol. 316: 941-953.
32. Llinas, P., Stura, E.A., Ménez, A., Kiss, Z., Stigbrand, T., Millán, J.L., and Le Du, M.H. 2005. Structural studies of human placental alkaline phosphatase in complex with functional ligands. J. Mol. Biol. 350: 441-451.
33. cat. Protein Eng. 4: 801-804.
34. Masella, M. 2006. The r-RESPA procedure and polarizable potentials based on induced dipoles. Mol. Phys. (in press).
35. 2, n = 1-6, and to small hydrogen bonded systems. J. Chem. Phys. 119: 1866-1873.
36. Matlin, A.R., Kendall, D.A., Carano, K.S., Banzon, J.A., Klecka, S.B., and Solomon, N.M. 1992. Enhanced catalysis by active-site mutagenesis at aspartic acid 153 in Escherichia coli alkaline phosphatase. Biochemistry 31: 8196-8200.
37. McComb, R.B., Bowers, G.N., and Posen, S. 1979. Alkaline phosphatases, pp. 986-989. Plenum Press, New York.
38. Meunier, P.J. and Reginster, J.Y. 2003. Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis. Osteoporos. Int. 14 (Suppl. 3): S66-S76.
39. Meyer, J.L. 1984. Can biological calcification occur in the presence of pyrophosphate? Arch. Biochem. Biophys. 231: 1-8.
40. Mornet, E. 2000. Hypophosphatasia: The mutations in the tissue-nonspecific alkaline phosphatase gene. Hum. Mutat. 15: 309-315.
41. Mornet, E., Stura, E., Lia-Baldini, A.S., Stigbrand, T., Ménez, A., and Ledu, M.H. 2001. Structural evidence for a functional role of human tissue non-specific alkaline phosphatase in bone mineralisation. J. Biol. Chem. 276: 31171-31178.
42. Moss, D.W., Eaton, R.H., Smith, J.K., and Whitby, L.G. 1967. Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations. Biochem. J. 102: 53-57.
43. Muller, B.H., Lamoure, C., Ledu, M.H., Cattolico, L., Lajeunesse, E., Lemaitre, F., Pearson, A., Ducancel, F., Menez, A., and Boulain, J.C. 2001. Improving Escherichia coli alkaline phosphatase efficacy by additional mutations inside and outside the catalytic pocket. Chembiochem 2: 517-523.
44. Murphy, J.E. and Kantrowitz, E.R. 1994. Why are mammalian alkaline phosphatases much more active than bacterial alkaline phosphatases? Mol. Microbiol. 12: 351-357.
45. Murphy, J.E., Stec, B., Ma, L., and Kantrowitz, E.R. 1997. Trapping and visualization of a covalent enzyme-phosphate intermediate. Nat. Struct. Biol. 4: 618-622.
46. Murshudov, G.N., Vagin, A.A., and Dodson, E.J. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53: 240-255.
47. Otwinowski, Z. and Minor, W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307-326.
48. Perrakis, A., Morris, R., and Lamzin, V.S. 1999. Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 6: 458-463.
49. Reginster, J.Y., Deroisy, R., and Jupsin, I. 2003. Strontium ranelate: A new paradigm in the treatment of osteoporosis. Drugs Today (Barc.) 39: 89-101.
50. Rinaldo, D., Vita, C., and Field, M.J. 2004. Engineering strontium binding affinity in an EF-hand motif: A quantum chemical and molecular dynamics study. J. Biomol. Struct. Dyn. 22: 281-297.
51. Roussel, A. and Cambillau, C. 1989. Silicon Graphics geometry partner directory, pp. 77-78. Silicon Graphics, Mountain View, CA.
52. Saarto, T., Janes, R., Tenhunen, M., and Kouri, M. 2002. Palliative radiotherapy in the treatment of skeletal metastases. Eur. J. Pain 6: 323-330.
53. Satow, Y., Cohen, G.H., Padlan, E.A., and Davies, D.R. 1986. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 Å. J. Mol. Biol. 190: 593-604.
54. Schrooten, I., Cabrera, W., Goodman, W.G., Dauwe, S., Lamberts, L.V., Marynissen, R., Dorriné, W., De Broe, M.E., and D'Haese, P.C. 1998. Strontium causes osteomalacia in chronic renal failure rats. Kidney Int. 54: 448-456.
55. Schrooten, I., Behets, G.J.S., Cabrera, W.E., Vercauteren, S.R., Lamberts, L.V., Verberckmoes, S.C., Bervoets, A.J., Dams, G., Goodman, W.G., De Broe, M.E., et al. 2003. Dose-dependent effects of strontium on bone of chronic renal failure rats. Kidney Int. 63: 927-935.
56. Schwartz, J.H. and Lipmann, F. 1961. Phosphate incorporation into alkaline phosphatase of E. coli.. Proc. Natl. Acad. Sci. 47: 1996-2005.
57. Smeland, S., Erikssen, B., Aas, M., Skovlund, E., Hess, S.L., and Fosså, S.D. 2003. Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: Results of a double-blind randomized study. Int. J. Radiat. Oncol. Biol. Phys. 56: 1397-1404.
58. Stec, B., Holtz, K.M., and Kantrowitz, E.R. 2000. A revised mechanism for the alkaline phosphatase reaction involving three metal ions. J. Mol. Biol. 299: 1303-1311.
59. Van Belle, H. 1976. Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin. Chem. 22: 972-976.
60. Verberckmoes, S.C., De Broe, M.E., and D'Haese, P.C. 2003. Dose-dependent effects of strontium on osteoblast function and mineralization. Kidney Int. 64: 534-543.
61. Weiss, M., Cole, D.E.C., Ray, K., Whyte, M., Laffeerty, M.A., Mulivor, R.A., and Harris, H. 1988. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc. Natl. Acad. Sci. 85: 7666-7669.
62. Whyte, M.P. 1994. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr. Rev. 15: 439-461.
63. _. 2001. Hypophosphatasia. In The metabolic and molecular bases of inherited disease (eds. C.R. Scriver et al.), pp. 5313-5329. McGraw-Hill, New York.
64. Xu, X. and Kantrowitz, E.R. 1991. A water-mediated salt link in the catalytic site of Escherichia coli alkaline phosphatase may influence activity. Biochemistry 30: 7789-7796.
65. Zurutuza, L., Muller, F., Gibrat, J.F., Taillandier, A., Simon-Bouy, B., Serre, J.L., and Mornet, A. 1999. Correlations of genotype and phenotype in hypophosphatasia. Hum. Mol. Genet. 8: 1039-1046.